Advertisement

Topics

CluePoints launches risk-based monitoring roadshow in Tokyo

14:41 EST 6 Nov 2017 | CentreWatch

CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has further expanded its Late Phase work in Japan by entering into two new partnerships with global top 20 pharmaceutical companies. The collaborations mark the latest success for CluePoints in the region, with its centralized statistical monitoring (CSM) platform having […]

The post CluePoints launches risk-based monitoring roadshow in Tokyo appeared first on CenterWatch News Online.

Original Article: CluePoints launches risk-based monitoring roadshow in Tokyo

NEXT ARTICLE

More From BioPortfolio on "CluePoints launches risk-based monitoring roadshow in Tokyo"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.